Everbridge is a China based medtech accelerator platform that is fully backed by CBC group, who is the largest healthcare focused fund in Asia. Our target is to bring innovative medtech products across the world to China by various of deal types, such as license-in, minority investment, or acquisition. Our key focus area is peripheral vascular intervention and neuro-vascular intervention.